SEC Filings for Aprea Therapeutics Inc. (APRE)

$ 26.86   0.48 (+1.82%) Volume: 159.96k 4:00 PM EDT May 29, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities105/21/2020
4Statement of changes in beneficial ownership of securities105/21/2020
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1505/22/2020
4Statement of changes in beneficial ownership of securities105/20/2020
4Statement of changes in beneficial ownership of securities105/20/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)9805/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)805/15/2020
DEFA14AAdditional proxy soliciting materials - definitive404/29/2020
DEF 14AOther definitive proxy statements4404/29/2020
4Statement of changes in beneficial ownership of securities104/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)304/03/2020
10-KAnnual report pursuant to Section 13 or 15(d)17103/27/2020
4Statement of changes in beneficial ownership of securities103/26/2020
8-KCurrent report pursuant to Section 13 or 15(d)803/26/2020
4Statement of changes in beneficial ownership of securities103/26/2020
<<
First
<
Prev
123456